1236 – Long-Acting Injectable CAB/MPA MPT Implant for Prevention of HIV and Unintended Pregnancy
Background Currently, there are 20.2 million girls and women living with HIV and nearly half of pregnancies are unintended. This leads to a global economic and health burden for women and as such, technologies that can prevent HIV infections and unintended pregnancies are warranted. We evaluated a long-acting (LA), injectable in-situ forming implant (ISFI) as a…